5月以来基金频发溢价风险提示；东方红资产管理拟自购1000万元

Group 1: Fund News - Minsheng Jianyin Fund announced the appointment of Zhu Yongming as the new deputy general manager on May 26, with Ding Hui taking over as the board secretary [1] - Over 80 funds have issued premium risk warnings since May, primarily affecting ETFs investing in markets such as the US, Saudi Arabia, and Germany [1][2] - Several fund companies have terminated cooperation with Minsheng Fund Sales (Shanghai) Co., Ltd., including Dongwu, Yin Hua, and Hua Tai Bai Rui [1] - Dongfanghong Asset Management plans to invest 10 million yuan in its core value mixed securities investment fund [1] Group 2: Notable Fund Manager Insights - Baoying Fund Manager Yao Yi expressed a long-term positive outlook on the growth potential of the innovative drug sector, suggesting investors adopt a longer-term perspective on investment value [2] - Yao Yi noted that while innovative drug stocks have rebounded significantly this year, a technical adjustment may occur after 3 to 4 months of accumulation, but the fundamental trends of the industry remain unchanged [2] Group 3: ETF Market Review - The market experienced fluctuations, with the Shanghai Composite Index down 0.18%, the Shenzhen Component down 0.61%, and the ChiNext Index down 0.68%, with total trading volume at 998.9 billion yuan, a decrease of 11 billion yuan from the previous trading day [3] - The Hong Kong Stock Connect innovative drug ETFs showed strong performance, with the highest increase of 3.88% [3][4] Group 4: Upcoming Fund Focus - The upcoming fund "Postal Savings Bank CSI Interbank Certificate of Deposit AAA Index 7-Day Holding" is an index-type fixed income fund managed by Wu Zhixiao, with a performance benchmark linked to the CSI Interbank Certificate of Deposit AAA Index [6]